Javier Camacho Selected Research

Breast Neoplasms (Breast Cancer)

11/2023	Enhancing Tamoxifen Therapy with α-Mangostin: Synergistic Antiproliferative Effects on Breast Cancer Cells and Potential Reduced Endometrial Impact.
1/2015	Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells.
10/2014	In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
3/2014	Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
12/2012	Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.
1/2012	Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
5/2011	Tamoxifen and its new derivatives in cancer research.
2/2010	Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
2/2007	Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Camacho Research Topics

Disease

40	Neoplasms (Cancer) 12/2023 - 10/2004
9	Breast Neoplasms (Breast Cancer) 11/2023 - 02/2007
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2023 - 10/2004
7	Fibrosis (Cirrhosis) 01/2023 - 08/2015
7	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2012
6	Carcinogenesis 09/2022 - 02/2010
4	Inflammation (Inflammations) 01/2022 - 01/2016
4	Retinoblastoma (Glioblastoma, Retinal) 08/2020 - 07/2017
4	Liver Cirrhosis (Hepatic Cirrhosis) 06/2019 - 12/2017
4	Lung Neoplasms (Lung Cancer) 01/2017 - 04/2011
2	Endometrial Neoplasms (Endometrial Cancer) 11/2023 - 05/2023
2	Neoplasm Metastasis (Metastasis) 05/2023 - 01/2022
2	Liver Neoplasms (Liver Cancer) 05/2023 - 01/2023
2	Uterine Cervical Dysplasia 05/2018 - 12/2011
2	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 03/2007
2	Body Weight (Weight, Body) 12/2017 - 10/2014
1	Channelopathies 12/2023
1	Adenocarcinoma 07/2022
1	Hepatic Encephalopathy 12/2018
1	Carcinoma (Carcinomatosis) 05/2018
1	Ovarian Neoplasms (Ovarian Cancer) 05/2018
1	Necrosis 01/2018
1	Cholestasis 01/2018
1	Leukemia 01/2017
1	Liver Diseases (Liver Disease) 01/2016
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2016

Drug/Important Bio-Agent (IBA)

17	Potassium Channels (Potassium Channel)IBA 12/2017 - 02/2006
12	Ion Channels (Ion Channel)IBA 12/2023 - 02/2007
12	Ether (Diethyl Ether)IBA 01/2020 - 02/2006
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2004
11	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 10/2004
9	AstemizoleIBA 01/2020 - 03/2011
7	Messenger RNA (mRNA)IBA 01/2020 - 10/2004
5	Antineoplastic Agents (Antineoplastics)IBA 05/2023 - 02/2010
5	Calcitriol (Calcijex)FDA LinkGeneric 10/2014 - 02/2010
4	Estrogen ReceptorsIBA 11/2023 - 05/2011
4	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2016
4	Histamine Receptors (Histamine Receptor)IBA 01/2020 - 03/2007
4	Ether-A-Go-Go Potassium ChannelsIBA 03/2011 - 10/2004
3	Tamoxifen FDA LinkGeneric 11/2023 - 05/2011
3	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2023 - 08/2015
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 01/2017
3	Estrogens (Estrogen)FDA Link 01/2020 - 04/2009
3	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2012
3	Hormones (Hormone)IBA 01/2020 - 02/2010
3	LipopolysaccharidesIBA 06/2019 - 08/2005
3	AntioxidantsIBA 05/2019 - 05/2016
3	Indicators and Reagents (Reagents)IBA 01/2018 - 04/2009
3	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2014 - 07/2010
2	PhytochemicalsIBA 11/2023 - 02/2023
2	mangostinIBA 11/2023 - 02/2023
2	CytokinesIBA 02/2023 - 01/2018
2	Histamine Antagonists (Antihistamines)IBA 01/2020 - 01/2017
2	AndrogensIBA 01/2020 - 03/2007
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2020 - 01/2012
2	steviosideIBA 06/2019 - 05/2019
2	Metalloproteases (Metalloproteinases)IBA 06/2019 - 12/2017
2	Ethanol (Ethyl Alcohol)IBA 06/2019 - 05/2019
2	Thioacetamide (Thioacetamid)IBA 06/2019 - 12/2018
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2018 - 04/2011
2	Estradiol (Delestrogen)FDA LinkGeneric 05/2018 - 01/2009
2	CollagenIBA 01/2018 - 06/2007
2	Epidermal Growth Factor (EGF)IBA 01/2015 - 01/2013
2	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2014 - 04/2009
2	Histamine (Histamine Dihydrochloride)FDA Link 03/2011 - 03/2007
1	afimoxifene (hydroxytamoxifen)IBA 11/2023
1	Sorafenib (BAY 43-9006)FDA Link 05/2023
1	Raloxifene Hydrochloride (Evista)FDA Link 05/2023
1	Loratadine (Alavert)FDA Link 05/2023
1	Drug CombinationsIBA 05/2023
1	AnnexinsIBA 01/2023
1	Annexin A1IBA 01/2023
1	C-Reactive ProteinIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 08/2020
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	DiterpenesIBA 06/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2019
1	Dopamine (Intropin)FDA LinkGeneric 12/2018
1	TeaIBA 12/2018
1	CarbonIBA 12/2018
1	iberiotoxinIBA 05/2018
1	Adenosine Triphosphate (ATP)IBA 05/2018
1	Glyburide (Glibenclamide)FDA LinkGeneric 05/2018
1	KATP ChannelsIBA 05/2018
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 05/2018
1	PotassiumIBA 05/2018
1	FlavonoidsIBA 12/2017
1	QuercetinIBA 12/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	1,1-diphenyl-2-picrylhydrazylIBA 05/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016
1	InterleukinsIBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016

Therapy/Procedure

20	Therapeutics 11/2023 - 02/2006
2	Precision Medicine 05/2023 - 07/2022
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
1	Drug Tapering 11/2023
1	Immunomodulation 12/2017